Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis

Objective. To study role of inflammation and disturbances of blood cholesterol transport system in atherosclerotic damage development in rheumatoid arthritis (RA). Material and methods. 84 RA pts with mean age 48 years and mean disease duration 87 months were included. Control group consisted of 15...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. V. Popkova, D S Novikova, A A Novikov, E N Alexandrova, E S Mach, T N Gawa, A. V. Masova, L A Gracheva, A A Bologov, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2007-10-01
Series:	Научно-практическая ревматология
Subjects:	inflammation rheumatoid arthritis atherosclerosis lipoprotein
Online Access:	https://rsp.mediar-press.net/rsp/article/view/298
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
by: A. A. Avagimyan, et al.
Published: (2025-04-01)

Cholesterol of Low-Density Lipoprotein-Containing Circulating Immune Complexes Improves Prognosis of Asymptomatic Carotid Atherosclerosis
by: A. N. Orekhov, et al.
Published: (2024-06-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis
by: S. S. Shabanova, et al.
Published: (2016-05-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
by: T V Popkova, et al.
Published: (2004-08-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01)

Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Emerging Biomarkers in Atherosclerosis: Advancing Early Detection and Risk Stratification
by: Aleksandra Sojka, et al.
Published: (2024-12-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

HDL cholesterol as a mediator of the relationship between breastfeeding and coronary atherosclerosis from a two-step Mendelian randomization analysis
by: Baoquan Zhang, et al.
Published: (2025-08-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

Role of inflammation in the development of cardiac autonomic disfunction in patients with systemic lupus erythematosus
by: D. S. Novikova, et al.
Published: (2008-12-01)

ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Tatiyana Valentinovna Popkova, et al.
Published: (2014-02-01)

Role of interleukin 1 in the development of atherosclerosis
by: E. L. Nasonov, et al.
Published: (2019-04-01)

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease
by: Alexandra V. Tyurina, et al.
Published: (2025-06-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

Human macrophage pro‐inflammatory polarization in response to free cholesterol and cholesterol remnants
by: Karel Paukner, et al.
Published: (2025-05-01)

Features of lipid metabolism disturbances in patients with rheumatoid arthritis
by: A E Sizikov, et al.
Published: (2009-04-01)

Risk factors of cardiovascular diseases in rheumatoid arthritis
by: T V Popkova, et al.
Published: (2009-06-01)

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY
by: E. L. Nasonov, et al.
Published: (2017-10-01)

Metabolic syndrome in patients with systemic lupus erythematosus
by: T Y Popkova, et al.
Published: (2008-08-01)

Relationship between C-reactive protein concentration, bone mineral density and cardiovascular disturbances in patients with rheumatoid arthritis
by: T. N. Gavva, et al.
Published: (2008-06-01)

SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
by: I. N. Ozerova, et al.
Published: (2017-12-01)

C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology
by: N V Seredavkina, et al.
Published: (2009-08-01)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020-03-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year‡
by: Núria Puig, et al.
Published: (2025-02-01)

ASSOCIATION BETWEEN THE DEGREE OF CORONARY ATHEROSCLEROSIS, RISK FACTORS, AND MARKERS OF CAROTID AND PERIPHERAL ARTERY ATHEROSCLEROSIS
by: N. E. Gavrilova, et al.
Published: (2013-02-01)

The Effect of Different Lipoproteins on the Severity of Coronary Atherosclerosis and Relation between them in Patients in Kurdistan
by: Marewan Hawil Saka, et al.
Published: (2023-04-01)

Peripheral plaque burden in the diagnosis of coronary atherosclerosis in rheumatoid arthritis
by: O. A. Fomicheva, et al.
Published: (2024-10-01)

Relationship between the white blood cell count and some lipid profile parameters in cancer patients with myocardial infarction
by: E. G. Skorodumova, et al.
Published: (2024-08-01)

Number of blood neutrophil granulocytes is associated with diffuse coronary involvement in patients with increased lipoprotein (a)
by: A. Yu. Filatova, et al.
Published: (2023-11-01)